Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.
- DOI
- 10.1016/j.fct.2008.05.029
- Published
- 2008 Aug
- Container
- Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.fct.2008.05.029,
title = {Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.},
author = {Wu KM and Ghantous H and Birnkrant DB},
year = {2008},
journal = {Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association},
doi = {10.1016/j.fct.2008.05.029},
url = {https://doi.org/10.1016/j.fct.2008.05.029}
}RIS
TY - JOUR TI - Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. AU - Wu KM AU - Ghantous H AU - Birnkrant DB PY - 2008 JO - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association DO - 10.1016/j.fct.2008.05.029 UR - https://doi.org/10.1016/j.fct.2008.05.029 ER -
APA
KM, W., H, G., & DB, B. (2008). Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States.. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. https://doi.org/10.1016/j.fct.2008.05.029
Source records
- pubmed · retrieved 2026-11-10T09:41:33.624Z
- europe-pmc · retrieved 2026-11-10T09:41:33.626Z